Navigation Links
St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial
Date:11/9/2009

St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.

Under the clinical protocol, St. Jude will refer patients to receive proton therapy at the UF Proton Therapy Institute in Jacksonville, Fla. The purpose of the clinical study is to improve response rates and decrease treatment-related side effects.

Proton therapy is being studied as a way to reduce potential damage to healthy tissue that may result from conventional radiation therapy. This is especially important in treating children with brain and spinal tumors to potentially avoid interference with development, growth and cognitive functioning.

St. Jude has the world's largest protocol-based, pediatric brain tumor research and treatment program, which puts it in an excellent position to scientifically document the advantages realized with proton beam radiation therapy.

"Proton beam therapy is potentially of great importance to St. Jude and our patients," said Dr. Joseph H. Laver, St. Jude executive vice president and clinical director. "Although most proton facilities operating in the U.S. recognize pediatrics as a major area of focus, there is very little meaningful data using this modality in children. Working with UF Proton Therapy Institute, we are well-positioned to answer key questions regarding this therapy for children with cancer."

St. Jude patients accepted for the clinical study will be in Jacksonville for proton therapy treatment for six to eight weeks. It is expected that up to 15 patients will receive treatment during the first year of the study. While in Jacksonville, hospital care for St. Jude patients will be provided by Nemours Children's Clinic Jacksonville and
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Historic Agreement Reached to More Expertly and Efficiently Expand Proton Therapy Worldwide
2. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
3. Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
4. Eclipse(TM) Proton Scanning Algorithm from Varian Medical Systems Receives FDA Clearance
5. Proton-powered pooping
6. Wyeth Announces Launch of Own Generic Version of PROTONIX
7. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
8. Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment
9. Gastric juice for diagnosis of H. pylori infection in patients on proton pump inhibitors
10. Varian Medical Systems to Develop Interface Between the ARIA(TM) Oncology Information System and the Monarch250(TM) Proton Radiotherapy System From Still River Systems
11. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-elec... Care Vote , Washington, ...essmen running for re-election next year in races ... Cook, may come to regret voting for House Speaker...to a breaking Zogby International/ O’Leary R...
(Date:11/20/2009)...N.J., Nov. 20 Rates of i... peaked in late October, but the pandemic flu viru... all age groups, including the elderly, according ...(NYSE: DGX ), the world,s leading provider of di... In its most recent Quest Diagnostics Health Trend...
(Date:11/20/2009).... 20 The American Denta...Drug Administration (FDA) to establish appropriate..., Citing concern about the safety of whitening ...enefit of professional consultation or examination...cation of chemically based tooth whitening or blea...
(Date:11/20/2009)..., Nov. 20 Centene Corp...l present at the Bank of America Merrill Lynch 200..., at the Crowne Plaza Hotel Times Square in New Yo...ember 2nd at 8:30 a.m. Eastern Time. Investors and... webcast of Centene,s presentation at: http://www...
(Date:11/20/2009)..., Israel, November 20 Ca...p://www.CVSLMEDICAL.COM , a leading,developer of a...nnounced that,the company,s Board of Directors has..., Canada and the Far East for its proprietary next...ll angioplasty (PCTA) procedures. , Cardi...
Breaking Medicine News(10 mins):Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
... Most Interesting Metabolic Projects,Available for...aera,Corporation (NASDAQ: GENR ) will present at ...erence being held November 3-5 at the Lowes Hotel ...eatment of type 2 diabetes and obesity on Tuesday,...
...ley,Corporation (Nasdaq: QGLY ), http://www.quig...g operations of $6.4 million, for the third quarte...on reported for the third quarter,ended September ...ember 30, 2007., The third quarter and nine month...
...ellmark Inc.,(Nasdaq: ORCH ), a leading worldwide...reported its financial results for the third quart...r the third quarter of 2008,compared to $15.6 mill...es in the U.K., Total U.S.-based revenues rose by...
...mber 6, 2008 at 1:30 p.m. (Pacific); ... , SAN DIEGO, Oct. 30 ADVENTRX Pharmaceuticals,I...t a conference call with,simultaneous webcast to d...t and Chief Financial Officer, is scheduled,to lea...
...e Survey Places Company Seventh in Atlanta Busines... Alpharetta, Ga. (Vocus) October 30, 2008-- Atlant... (JH) one of "Atlanta,s Best Places to Work&... 20 medium-size companies (101-500 employees), acc...
...by SEIU,Secretary-Treasurer Anna Burger on Barack ... moment. In six days, voters will head to the poll...r rescuing our nation from,the biggest economic cr...e class, affordable,healthcare for all, a real sol...
Other Medicine News:Health News:Genaera to Present at Therapeutic Area Partnerships 2008 2Health News:The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future 2Health News:The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future 3Health News:The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future 4Health News:The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future 5Health News:The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future 6Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 8Health News:Jackson Healthcare Is Named Among "Atlanta's Best Places to Work" 2Health News:Jackson Healthcare Is Named Among "Atlanta's Best Places to Work" 3
(Date:11/20/2009)...Nov. 20 Unilens Vision I...ge: UVI), which develops, licenses, manufactures, ...today reported its operating results for the first...Net sales excluding royalty income, were $1,683,67...61,526 reported in the previous year first quarter...
(Date:11/20/2009)...Nov. 20 Cornerstone Ther...ceutical company focused on acquiring, developing ... for the respiratory and related markets, today re...the Food and Drug Administration ("FDA") alleging ...ne HCl 10 mg, Pyrilamine Maleate 16 mg) and Decons...
(Date:11/20/2009)...Ky., Nov. 20 The National Associ...y announced a new initiative in the war on methamp...LEx) is a multi-state electronic tracking program ...nter (OTC) medicines containing pseudoephedrine in...or NPLEx is based on a system that was developed a...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays 3F ECRI Institute outlines best practices to ensure bette 5783 1Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays 3F ECRI Institute outlines best practices to ensure bette 5783 2Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays 3F ECRI Institute outlines best practices to ensure bette 5783 32009 Annual Meetings emphasize sustainability 10554 12009 Annual Meetings emphasize sustainability 10554 2Let Kids Sleep Late on Weekends to Fight Fat 3A Study 60231 1Let Kids Sleep Late on Weekends to Fight Fat 3A Study 60231 2Let Kids Sleep Late on Weekends to Fight Fat 3A Study 60231 3
Colorcard® Streptozyme® Streptococcal Antibody Test
Virogen® Rotatest® Rotavirus Test
Mono-Test® Mononucleosis Test
...sional Diagnostics is a leading provider of immuno... test menu that includes kits for autoimmune disea...llaneous conjugates and components. Our Impact IFA...ates and kit sizes to choose from. Kit components ...
Medicine Products: